Evli Pankki Oyj - Decisions of general meeting

Decisions taken by Evli Bank Plc's Annual General Meeting and Board of Directors on March 8, 2016

EVLI BANK PLC STOCK EXCHANGE RELEASE MARCH 8, 2016, AT 12.15 PM

Decisions taken by Evli Bank Plc's Annual General Meeting and Board of Directors
on March 8, 2016

Evli Bank Plc's Annual General Meeting on March 8, 2016 approved the financial
statements and discharged the members of the Board of Directors and the
company's CEO from liability for the financial year 2015. The Meeting approved
the Board of Directors' proposal to pay a dividend of EUR 0.31 per share. The
dividend will be paid to shareholders who are recorded in the company's
shareholder register maintained by Euroclear Finland Ltd. The record date is
March 10, 2016. The dividend will be paid on March 17, 2016.

Board of Directors and Auditor
The Annual General Meeting decided that the Board of Directors will consist of
seven members. The following people were re-elected to the Board of Directors:
Henrik Andersin, Robert Ingman, Harri-Pekka Kaukonen, Johanna Lamminen, Mikael
Lilius, Teuvo Salminen and Thomas Thesleff.

It was decided that the following remuneration shall be paid to the members of
the Board of Directors: EUR 4,100.00 per month to the Members of the Board and
EUR 6,000.00 per month to the Chairman. In addition, the Chairmen of the
Committees will be paid EUR 800.00 for each Committee meeting.

The auditing firm KPMG Oy Ab was elected as the company's auditor and Marcus
Tötterman, APA, as the principally responsible auditor. The auditor shall be
paid a remuneration according to a reasonable invoice approved by the company.

Authorizing the Board of Directors to decide on the repurchase of the company's
own shares
The Annual General Meeting authorized the Board of Directors to decide on the
repurchase of the company's own series A and series B shares in one or more lots
as follows:



The total number of own series A shares to be repurchased may be a maximum of
1,696,213 shares, and the total number of own series B shares to be repurchased
may be a maximum of 635,178 shares, which corresponds to a total of
approximately 10 percent of the total number of company's own shares on the date
of the Notice of Annual General Meeting. On the basis of the authorization, the
company's own shares may only be repurchased with unrestricted equity. The
company's own shares may be repurchased at the price formed for series B shares
in public trading or at the price otherwise formed on the market on the purchase
day.



The Board of Directors will decide how the company's own shares will be
repurchased. Financial instruments such as derivatives may be used in the
purchasing. The company's own shares may be repurchased in other proportion than
the shareholders' proportional shareholdings (private purchase). The
authorization will replace earlier unused authorizations to repurchase the
company's own shares. The authorization will be in force until the next Annual
General Meeting but no later than until June 30, 2017.



Authorizing the Board of Directors to decide on the issuance of shares as well
as the issuance of options and other special rights entitling to shares
The Annual General Meeting authorized the Board of Directors to decide on the
issuance of shares and special rights entitling to shares pursuant to chapter
10, section 1, of the Limited Liability Companies Act in one or more lots, for a
fee or free of charge.



Based on the authorization, the number of shares issued or transferred,
including shares received on the basis of special rights, may total a maximum of
2,331,392 series B shares, which corresponds to approximately 10% of the current
total number of all the shares of the company. Of the above-mentioned total
number, however, a maximum of 233,139 shares may be used as part of the
company's share-based incentive schemes, which corresponds to approximately 1%
of the current total number of all the shares of the company.



The authorization will entitle the Board of Directors to decide on all the terms
and conditions related to the issuing of shares and special rights entitling to
shares, including the right to deviate from the shareholders' pre-emptive
subscription rights. The Board of Directors may decide to issue either new
shares or any own shares in the possession of the company.



The authorization will replace earlier unused authorizations concerning the
issuance of shares as well as the issuance of options and other special rights
entitling to shares. The authorization is in force until the end of the next
Annual General Meeting but no longer than until June 30, 2017.



The minutes of the meeting will be available on www.evli.com/agm as of March
22, 2016 at the latest.



Decisions by the Board of Directors
The organisational meeting of the Board of Directors elected from among its
members Henrik Andersin as its Chairman and Harri-Pekka Kaukonen as its Vice
Chairman.

Teuvo Salminen was elected as Chairman and Johanna Lamminen and Robert Ingman as
members of the Audit Committee. Harri-Pekka Kaukonen was elected as Chairman and
Henrik Andersin, Mikael Lilius and Thomas Thesleff as members of the
Compensation and Nomination Committee. Harri-Pekka Kaukonen, Johanna Lamminen,
Mikael Lilius ja Teuvo Salminen are independent of both the company and of
significant shareholders.

EVLI BANK PLC


For additional information, please contact:

Juho Mikola, CFO, Evli Bank Plc, tel. +358 (0)9 4766 9871, juho.mikola@evli.com

Evli Bank Plc in brief

Evli is a genuine private bank specializing in investment that helps private
persons and institutions increase their wealth. The company offers asset
management services, capital markets related services, such as brokerage of
equities and other instruments, market making, investment research and a full
range of Corporate Finance services.


Distribution: Nasdaq Helsinki Ltd, main media, www.evli.com





[HUG#1992381]